CD19 and interstitial lung disease: However, the number of CD3-CD19+ cells was higher, and the incidence of RP-ILD was higher than that in other subgroups, which was consistent with the previous literature that anti-PL12 positive patients were more likely to develop RP-ILD (3, 7, 21, 22).